Avid Bioservices, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2024 12 months to Apr 30, 2024	FY2023 12 months to Apr 30, 2023	FY2022 12 months to Apr 30, 2022	FY2021 12 months to Apr 30, 2021	FY2020 12 months to Apr 30, 2020
Revenues
Cost of revenues
Gross profit
Operating expenses:
Selling, general and administrative
Loss on lease termination
Restructuring charges

Total operating expenses
Operating income (loss)
Interest expense
Other income (expense), net
Net income (loss) before income taxes
Income tax (benefit) expense
Income from discontinued operations, net of tax
Net income (loss)
Comprehensive income (loss)
Series E preferred stock accumulated dividends
Impact of Series E preferred stock redemption
Net income attributable to common stockholders
Net income (loss) per share attributable to common stockholders, basic and diluted - Continuing operations
Net income (loss) per share attributable to common stockholders, basic and diluted - Discontinued operations
Basic and diluted weighted average common shares outstanding
Net income (loss) per share:
Basic
Diluted
Weighted average common shares outstanding:
Basic
Diluted

Comments